Evidence map›Paper›PMID 39409884›Full record

ArticleCancers2024

Signature Genes Selection and Functional Analysis of Astrocytoma Phenotypes: A Comparative Study.

Anna Drozdz, Caitriona E McInerney, Kevin M Prise, Veronica J Spence, Jose Sousa

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna DrozdzSano-Centre for Computational Personalised Medicine-International Research Foundation, Czarnowiejska 36, 30-054 Kraków, Poland.ORCID 0000-0003-3999-6725
Caitriona E McInerneyPatrick G. Johnson Centre for Cancer Research, Queen's University Belfast, BT9 7AE Belfast, Ireland.ORCID 0000-0002-8985-2909
Kevin M PrisePatrick G. Johnson Centre for Cancer Research, Queen's University Belfast, BT9 7AE Belfast, Ireland.ORCID 0000-0001-6134-7946
Veronica J SpencePatrick G. Johnson Centre for Cancer Research, Queen's University Belfast, BT9 7AE Belfast, Ireland.
Jose SousaSano-Centre for Computational Personalised Medicine-International Research Foundation, Czarnowiejska 36, 30-054 Kraków, Poland.ORCID 0000-0001-9570-6054

Funding

Brainwaves Northern Ireland Registered Charity Number: NIC103464European Union's Horizon 2020 research and innovation programme 857533International Research Agendas programme of the Foundation for Polish Science MAB PLUS/2019/13
6 · The paper itself

Abstract

Novel cancer biomarkers discoveries are driven by the application of omics technologies. The vast quantity of highly dimensional data necessitates the implementation of feature selection. The mathematical basis of different selection methods varies considerably, which may influence subsequent inferences. In the study, feature selection and classification methods were employed to identify six signature gene sets of grade 2 and 3 astrocytoma samples from the Rembrandt repository. Subsequently, the impact of these variables on classification and further discovery of biological patterns was analysed. Principal component analysis (PCA), uniform manifold approximation and projection (UMAP), and hierarchical clustering revealed that the data set (10,096 genes) exhibited a high degree of noise, feature redundancy, and lack of distinct patterns. The application of feature selection methods resulted in a reduction in the number of genes to between 28 and 128. Notably, no single gene was selected by all of the methods tested. Selection led to an increase in classification accuracy and noise reduction. Significant differences in the Gene Ontology terms were discovered, with only 13 terms overlapping. One selection method did not result in any enriched terms. KEGG pathway analysis revealed only one pathway in common (cell cycle), while the two methods did not yield any enriched pathways. The results demonstrated a significant difference in outcomes when classification-type algorithms were utilised in comparison to mixed types (selection and classification). This may result in the inadvertent omission of biological phenomena, while simultaneously achieving enhanced classification outcomes.

Indexed as

artificial intelligenceastrocytomabrain cancerclassificationfeature selectionmachine learningmicroarrayspatient stratificationprecision medicinesignature genes

Identifiers

PMID39409884
PMCPMC11476064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.